* BioHiTech Global Inc BHTG.OQ BHTG.O is expected to show a
rise in quarterly revenue when it reports results on November
17 (estimated).
* The Chestnut Ridge, New York-based company is expected to
report a 325.6% increase in revenue to $3.161 million from
$742.88 thousand a year ago, according to the mean estimate from
3 analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for BioHiTech Global Inc is
for a loss of 6 cents per share. For the same quarter last year,
the company reported a loss of 12 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for BioHiTech
Global Inc is $5, about 76.4% above its last closing price
of $1.18.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2021 -0.07 -0.07 -0.09 Missed -28.6
Mar. 31 2021 -0.09 -0.08 -0.07 Beat 17.6
Dec. 31 2020 -0.08 -0.08 -0.14 Missed -75
Sep. 30 2020 -0.13 -0.13 -0.12 Beat 7.7
Jun. -0.11 -0.11 -0.16 Missed -45.5
30 2020
Mar. 31 2020 -0.13 -0.13 -0.16 Missed -23.1
Dec. 31 2019 -0.15 -0.15 -0.15 Met 0
Sep. 30 2019 -0.06 -0.06 -0.16 Missed -166.7
This summary was machine generated November 15 at 21:13 GMT.
All figures in US dollars unless otherwise stated